MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,350,000 | -70.5% | 52,902 | -47.3% | 0.33% | -66.5% |
| Q4 2021 | $14,736,000 | +68.8% | 100,455 | +103.5% | 0.98% | +86.2% |
| Q3 2021 | $8,731,000 | -45.2% | 49,355 | -50.0% | 0.53% | -39.0% |
| Q2 2021 | $15,945,000 | +508.1% | 98,715 | +545.0% | 0.87% | +641.0% |
| Q1 2021 | $2,622,000 | -24.0% | 15,305 | -2.5% | 0.12% | -52.2% |
| Q4 2020 | $3,449,000 | -69.5% | 15,705 | -77.0% | 0.24% | -69.9% |
| Q3 2020 | $11,320,000 | -23.7% | 68,170 | -47.5% | 0.81% | -43.9% |
| Q2 2020 | $14,838,000 | +78.2% | 129,960 | +20.0% | 1.45% | +75.4% |
| Q1 2020 | $8,325,000 | – | 108,300 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |